Annual EBIT
-$34.78 M
0.00%
31 December 2023
Summary:
Rapport Therapeutics annual earnings before interest & taxes is currently -$34.78 millionRAPP annual EBIT is now at all-time high.RAPP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$21.64 M
-$840.00 K-4.04%
30 September 2024
Summary:
Rapport Therapeutics quarterly earnings before interest & taxes is currently -$21.64 million, with the most recent change of -$840.00 thousand (-4.04%) on 30 September 2024. Over the past year, it has dropped by -$8.25 million (-61.60%). RAPP quarterly EBIT is now -316.88% below its all-time high of -$5.19 million, reached on 31 March 2023.RAPP Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$72.92 M
-$12.08 M-19.85%
30 September 2024
Summary:
Rapport Therapeutics TTM earnings before interest & taxes is currently -$72.92 million, with the most recent change of -$12.08 million (-19.85%) on 30 September 2024. Over the past year, it has dropped by -$44.78 million (-159.10%). RAPP TTM EBIT is now -1304.84% below its all-time high of -$5.19 million, reached on 31 March 2023.RAPP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RAPP EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -61.6% | -159.1% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
RAPP EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | at low | -316.9% | at low | -1304.8% | at low |
| 5 y | 5 years | at high | at low | -316.9% | at low | -1304.8% | at low |
| alltime | all time | at high | at low | -316.9% | at low | -1304.8% | at low |
Rapport Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$21.64 M(+4.0%) | -$72.92 M(+19.8%) |
| June 2024 | - | -$20.80 M(+21.7%) | -$60.85 M(+51.9%) |
| Mar 2024 | - | -$17.09 M(+27.7%) | -$40.05 M(+42.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$34.78 M | -$13.39 M(+40.0%) | -$28.15 M(+90.8%) |
| Sept 2023 | - | -$9.56 M(+84.2%) | -$14.76 M(+184.2%) |
| Mar 2023 | - | -$5.19 M | -$5.19 M |
FAQ
- What is Rapport Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Rapport Therapeutics?
- What is Rapport Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Rapport Therapeutics?
- What is Rapport Therapeutics quarterly EBIT year-on-year change?
- What is Rapport Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Rapport Therapeutics?
- What is Rapport Therapeutics TTM EBIT year-on-year change?
What is Rapport Therapeutics annual earnings before interest & taxes?
The current annual EBIT of RAPP is -$34.78 M
What is the all time high annual EBIT for Rapport Therapeutics?
Rapport Therapeutics all-time high annual earnings before interest & taxes is -$34.66 M
What is Rapport Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of RAPP is -$21.64 M
What is the all time high quarterly EBIT for Rapport Therapeutics?
Rapport Therapeutics all-time high quarterly earnings before interest & taxes is -$5.19 M
What is Rapport Therapeutics quarterly EBIT year-on-year change?
Over the past year, RAPP quarterly earnings before interest & taxes has changed by -$8.25 M (-61.60%)
What is Rapport Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of RAPP is -$72.92 M
What is the all time high TTM EBIT for Rapport Therapeutics?
Rapport Therapeutics all-time high TTM earnings before interest & taxes is -$5.19 M
What is Rapport Therapeutics TTM EBIT year-on-year change?
Over the past year, RAPP TTM earnings before interest & taxes has changed by -$44.78 M (-159.10%)